Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Fulgent Genetics United States | 509 | 275 |
|
Neuromuscular Channelopathies , Panel Massive Sequencing (NGS) 44 Genes Reference Laboratory Genetics Spain | 60 | 44 |
|
Early Infantile Epileptic Encephalopathy , Panel Massive Sequencing (NGS) 30 Genes Reference Laboratory Genetics Spain | 28 | 28 |
|
Epilepsy Advanced Sequencing and CNV Evaluation-Epileptic Encephalopathy Athena Diagnostics United States | 66 | 67 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 143 | 135 |
|
Asper Biogene Asper Biogene LLC Estonia | 210 | 204 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Epileptic encephalopathy, early infantile type XII Bioarray Spain | 1 | 1 |
|
Epileptic encephalopathy, early infantile Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Epilepsy and X-linked Mental Retardation with Seizures Panel CeGaT GmbH Germany | 21 | 25 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Epileptic encephalopathy panel Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 53 | 32 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.